CR20130565A - FUSIONATES DERIVED FROM USEFUL IMIDAZOL AS IDO INHIBITORS - Google Patents
FUSIONATES DERIVED FROM USEFUL IMIDAZOL AS IDO INHIBITORSInfo
- Publication number
- CR20130565A CR20130565A CR20130565A CR20130565A CR20130565A CR 20130565 A CR20130565 A CR 20130565A CR 20130565 A CR20130565 A CR 20130565A CR 20130565 A CR20130565 A CR 20130565A CR 20130565 A CR20130565 A CR 20130565A
- Authority
- CR
- Costa Rica
- Prior art keywords
- fusionates
- imidazol
- derived
- useful
- ido inhibitors
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El triptófano (Trp) es un aminoácido esencial necesario para la biosíntesis de proteínas, niacina y del neurotransmisor 5 hidroxitriptamina (serotonina). La enzima indoleamina 2,3 dioxigenasa (también conocida como INDO o IDO) cataliza el primer paso que limita la tasa de degradación de L triptófano en N formil quinureninaTryptophan (Trp) is an essential amino acid necessary for the biosynthesis of proteins, niacin and the neurotransmitter 5 hydroxytryptamine (serotonin). The enzyme indoleamine 2,3 dioxygenase (also known as INDO or IDO) catalyzes the first step that limits the degradation rate of L tryptophan in N formyl quinurenine
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CR20130565A CR20130565A (en) | 2013-11-04 | 2013-11-04 | FUSIONATES DERIVED FROM USEFUL IMIDAZOL AS IDO INHIBITORS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CR20130565A CR20130565A (en) | 2013-11-04 | 2013-11-04 | FUSIONATES DERIVED FROM USEFUL IMIDAZOL AS IDO INHIBITORS |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20130565A true CR20130565A (en) | 2014-05-26 |
Family
ID=50884156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20130565A CR20130565A (en) | 2013-11-04 | 2013-11-04 | FUSIONATES DERIVED FROM USEFUL IMIDAZOL AS IDO INHIBITORS |
Country Status (1)
Country | Link |
---|---|
CR (1) | CR20130565A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017075341A1 (en) * | 2015-10-29 | 2017-05-04 | Scifluor Life Sciences, Inc. | Fused imidazole derivatives as ido/tdo inhibitors |
CN107176956A (en) * | 2017-05-31 | 2017-09-19 | 成都海博锐药业有限公司 | A kind of IDO inhibitor compound, Pharmaceutical composition, purposes |
WO2017198159A1 (en) * | 2016-05-16 | 2017-11-23 | 鲁南制药集团股份有限公司 | Imidazole derivative containing bridge ring |
CN107488179A (en) * | 2016-06-11 | 2017-12-19 | 鲁南制药集团股份有限公司 | Imidazoles 01 derivatives containing bridged ring |
WO2018045966A1 (en) * | 2016-09-12 | 2018-03-15 | 广州必贝特医药技术有限公司 | Imidazole-containing fused tricyclic compounds and applications thereof |
-
2013
- 2013-11-04 CR CR20130565A patent/CR20130565A/en unknown
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017075341A1 (en) * | 2015-10-29 | 2017-05-04 | Scifluor Life Sciences, Inc. | Fused imidazole derivatives as ido/tdo inhibitors |
US10308647B2 (en) | 2015-10-29 | 2019-06-04 | Scifluor Life Sciences, Inc. | Fused imidazole derivatives as IDO/TDO inhibitors |
WO2017198159A1 (en) * | 2016-05-16 | 2017-11-23 | 鲁南制药集团股份有限公司 | Imidazole derivative containing bridge ring |
CN107488179A (en) * | 2016-06-11 | 2017-12-19 | 鲁南制药集团股份有限公司 | Imidazoles 01 derivatives containing bridged ring |
WO2018045966A1 (en) * | 2016-09-12 | 2018-03-15 | 广州必贝特医药技术有限公司 | Imidazole-containing fused tricyclic compounds and applications thereof |
CN107176956A (en) * | 2017-05-31 | 2017-09-19 | 成都海博锐药业有限公司 | A kind of IDO inhibitor compound, Pharmaceutical composition, purposes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY34736A (en) | ? INDOL AND INDAZOL COMPOUNDS THAT ACTIVATE AMPK ?. | |
ECSP17016797A (en) | INDAZOLES SUBSTITUTED WITH BENZYL AS BUB1 INHIBITORS | |
CR20130565A (en) | FUSIONATES DERIVED FROM USEFUL IMIDAZOL AS IDO INHIBITORS | |
EA201891910A1 (en) | PAD4 HETEROARYLINARY INHIBITORS | |
CL2016001082A1 (en) | Process for the synthesis of an indolamine 2,3-dioxygenase inhibitor | |
CL2015002932A1 (en) | Protein kinase inhibitors | |
BR112016023851A2 (en) | ? two-part coating composition and method for coating a surface? | |
EA201691594A1 (en) | CYCLOPROPYLAMINES AS LSD1 INHIBITORS | |
EA202090632A1 (en) | METHODS AND COMPOSITIONS FOR TREATING DISORDERS WITH THE USE OF FALLISTATIN POLYPEPTIDES | |
EA201592005A1 (en) | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS | |
UY35798A (en) | INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEIVER | |
PE20151594A1 (en) | INDOLAMINE 2-3 DIOXYGENASE INHIBITORS | |
MX2017003637A (en) | Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors. | |
EA201692435A1 (en) | CONNECTION SALTS (S) -2- (1- (6-AMINO-5-CYANOPYRIMIDIN-4-ILAMINO) ETIH) -4-OXO-3-PHENYL-3,4-DIGYDROPYRROLO [1,2-F] [1, 2,4] TRIAZIN-5-CARBONITRILE | |
UY35464A (en) | KRAS G12C COVALENT INHIBITORS. | |
MX2016012368A (en) | Combinations of an fgfr inhibitor and an igf1r inhibitor. | |
UY35385A (en) | ? METHODS AND COMPOSITIONS FOR WEED CONTROL ?. | |
LT3424920T (en) | Co-crystals of (s)-n-methyl-8-(1-((2`-methyl-[4,5`-bipyrimidin]-6-yl)amino)propan-2-yl)quinoline-4-carboxamide and deuterated derivatives thereof as dna-pk inhibitors | |
UY34342A (en) | ? DERIVATIVES OF PIRROLOPIRIMIDINA AND PURINA ?. | |
EA201691032A1 (en) | IZHOCHROMEN DERIVATIVES AS PHOSFOINOSYTID-3-KINAZ INHIBITORS | |
EA201692313A1 (en) | Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase | |
EA201891347A1 (en) | Aza-benzimidazole inhibitors PAD4 | |
EA201791530A1 (en) | NEW N-ACYLARYL SULPHONAMIDE DERIVATIVES AS AN INHIBITORS AMINOACYL-tRNA SYNTHETASIS | |
CY1122403T1 (en) | DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE | |
BR112017011642A2 (en) | compound, pharmaceutically acceptable salt, and method for treating a disease or condition that benefits from an increase in nad +. |